Hypoxia is a major characteristic of the tumor microenvironment, and its effects on immune cells are proposed to be important factors for the process of tumor immune escape. It has been reported that hypoxia affects the function of dendritic cells and the antitumor function of T cells. Here we discuss the effects of hypoxia on T-cell survival. Our results showed that hypoxia induced apoptosis of T cells. Adenosine and adenosine receptors (AR) are important to the hypoxia-related signaling pathway. Using AR agonists and antagonists, we demonstrated that hypoxia-induced apoptosis of T cells was mediated by A 2a and A 2b receptors. Furthermore, we are the first, to our knowledge, to report that hypoxia significantly inhibited the expression of chemokine C receptor 7 (CCR7) of T cells via the A 2 R signal pathway, perhaps representing a mechanism of hypoxia-induced apoptosis of T cells. Collectively, our research demonstrated that hypoxia induces T-cell apoptosis by the A 2 R signaling pathway partly by suppressing CCR7. Blocking the A 2 R signaling pathway and/or activation of CCR7 can increase the anti-apoptosis function of T cells and may become a new strategy to improve antitumor potential.
INTRODUCTION
Tumor-associated immune escape indicates that tumor microenvironment plays immunosuppressive roles in innate and adaptive immune responses. 1 Hypoxia is one of the common characteristics of solid tumor environments. It can affect the function and survival of immune cells that promote the escape of tumor cells. 2, 3 We and others have previously demonstrated that hypoxia inhibited the maturation and migration of dendritic cells and indirectly affected T-cell activation and functioning. [4] [5] [6] Acting primarily as effecter cells in tumor immunity, T cells are likely to encounter significant differences in oxygen tension, and the direct responses of T cells to hypoxia, therefore, may be an issue of concern. 7 Various in vitro studies have indicated that hypoxia can affect the functions of T cells. Hypoxia significantly inhibited lymphocyte expression of interleukin 2 and proliferation [8] [9] [10] and altered T-lymphocyte development and effector functions. 11 Recently, Kiang et al. have shown that hypoxia triggered a series of biochemical alterations leading to apoptosis of Jurcat T cells. 12 Whether hypoxia induces apoptosis of peripherally derived T cells is unclear.
Adenosine and adenosine receptor (AR) are essential components of the hypoxia-associated signaling pathway. Adenosine is an endogenous purine nucleoside and hypoxia can induce adenosine accumulation in the extracellular environment mainly through regulation of cellular metabolism. 13 By interacting with G-protein-coupled receptors, adenosine can exert substantial immunosuppressive effects. 14, 15 There are currently four clearly defined AR subtypes:
G i -protein-coupled A 1 and A 3 receptors, and G s -protein-coupled A 2a and A 2b receptors. 16, 17 T cells predominantly express A 2a R and A 2b R, [17] [18] [19] depending on which adenosine inhibits T-cell-receptortriggered activation and proliferation of T cells. 20, 21 Deficiency of adenosine deaminase, a ubiquitous enzyme in the purine catabolic pathway, causes apoptosis of CD8 low-transitional and CD4
1 CD8 1 double-positive thymocytes. 22 Furthermore, T-cell apoptosis was abundant in the thymi of adenosine deaminase (2/2) mice. 23 These results indicate that the adenosine signaling pathway is associated with T-cell survival. However, the role of adenosine and AR in the regulation of T-cell survival during hypoxia is unknown.
Chemokine C receptor 7 (CCR7) is an important mediator for lymphocyte homing. 24 It has also been reported that CCR7 plays an essential role in T-cell differentiation and two subsets of memory T cells were distinguished depending on the expression of CCR7. 25 Recently, a novel anti-apoptotic role for CCR7 was described in T cells, 26, 27 and it was shown that the expression of CCR7 is regulated by hypoxia.
6,28 Therefore, we hypothesize that CCR7 may play an essential role in hypoxia-induced apoptosis of T cells. The primary goals of the present study were to elucidate the effect of hypoxia on T-cell apoptosis and to clarify the roles of the AR signal and CCR7 in this process.
for A 1 receptor, 2-[p-2-(carboxy-ethyl)-phenylethylamino]-59-Nethylcarboxamidoadenosine (CGS21680), an agonist specific for A 2a receptor, N 6 -(3-iodobenzyl)adenosine-5'-N-methylluronamide (IB-MECA), an agonist specific for A 3 receptor, 5-amino-2-(2-furyl)-7-phenylethyl-pyrazolo-[4,3-e]-1,2,4-triazolo [1,5-c] pyrimidine (SCH58261), an antagonist specific for A 2a receptor, phytohaemagglutinin, lipopolysaccharide (LPS), Ficoll and nylon were all obtained from Sigma (St. Louis, MO, USA). N-(4-acetylphenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl) phenoxy] acetamide (MRS1706), an antagonist specific for A 2b receptor was from Tocris (St. Louis, MO, USA). RPMI 1640 medium and fetal bovine serum was from Bio International (Auckland, New Zealand). Phycoerythrin (PE)-conjugated anti-CCR7 monoclonal antibody (mAb) and PE-Cy5-conjugated anti-CD3 mAb were purchased from BD PharMingen (San Diego, CA, USA). Annexin V/FITC Kit was from Bender Medsystems (Vienna, Austria).
Cell isolation and culture
Human peripheral blood mononuclear cells were isolated from heparinized blood of healthy donors (n514) by Ficoll density gradient centrifugation, and suspended in serum-free RPMI 1640 medium. Next, peripheral blood mononuclear cells were cultured on six-well plates for 1 h at 37 uC to remove adherent monocytes, and then T lymphocytes were harvested using a nylon column. T cells were then resuspended in RPMI 1640 medium supplemented with 10% fetal calf serum and 5 mg/ml phytohemagglutinin at a density of 1310 6 cells/ml. One milliliter of the cell suspension was seeded per well into 12-well plates, with or without AR agonists/antagonists at normoxic (21% O 2 , 5% CO 2 , 74% N 2 ) or hypoxic (1% O 2 , 5% CO 2 , 95% N 2 ) conditions as indicated.
Normoxic and hypoxic culture conditions
To acquire normoxic conditions, the isolated T cells were incubated in a humidified cell culture incubator (HERA Cell 150, Kendro Laboratory Products GmbH, Langenselbold, Germany; 21% O 2 , 5% CO 2 and 74% N 2 ). Hypoxic incubation was performed in a sealed, anaerobic work station (Concept 400, Ruskin Technologies, Pencoed, Wales, UK), in which the hypoxic environment (1% O 2 , 94% N 2 and 5% CO 2 ), temperature (37 uC), and humidity (90%) were kept constant.
Apoptosis assay T cells were cultured under the indicated conditions. After 24 h, cells were harvested and stained with 5 ml Annexin V-fluoresceine isothiocyanate (FITC) and 10 ml propidium iodide in binding buffer for 15 min according to the protocol provided by the manufacturer. The percentage of apoptotic cells was determined by flow cytometry.
Flow cytometric analysis
After stimulation, T cells were collected and washed with cold phosphate-buffered saline three times, then labeled with mouse antihuman PE-conjugated anti-CCR7 mAb and PE-Cy5-conjugated anti-CD3 mAb for 20 min in the dark. The cells were also stained with the corresponding mouse antihuman isotype-matched control antibodies. Then cells were washed with cold phosphate-buffered saline three times. The expression of CCR7 on CD3
1 T cells was assayed by flow cytometer (FACSCalibur; Becton Dickinson, Mountain View, CA, USA). A minimum of 10 000 events per sample were collected for phenotypic analysis.
RNA extraction and reverse transcriptase polymerase chain reaction Total RNA was isolated with Trizol according to the manufacturer's instruction. The RNA concentration was quantified by UV spectrophotometry at 260 nm and the purity and integrity was determined using the A260/A280 ratio and lab-on-chip assay (Agilent bioanalyzer, Santa Clara, CA, USA). Total RNA was treated with DNase (Fermentas, Burlington, Ontario, Canada), and then reverse-transcribed using RevertAid M-MuLV Reverse Transcriptase (Fermentas) with Oligo dT primers (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. One microliter of single-strand cDNA was used as a template for the polymerase chain reaction reaction with DNA polymerase (Invitrogen). Polymerase chain reaction amplification was performed after a hot start at 95 uC for 5 min followed by 30 cycles (94 uC for 30 s, 57 uC for 30 s and 72 uC for 45 s), with a final extension at 72 uC for 7 min. The housekeeping gene b-actin was used as an internal control for the normalization of RNA quantity and quality differences among the samples. Primer pairs for amplification are shown in Table 1 .
Statistical analysis
A paired t-test was used in the analysis of CCR7 expression and the T-cell apoptosis. For each test, P-values less than 0.05 (P,0.05) were considered statistically significant. All the statistical analyses were performed using SPSS version 11.5 for Windows (SPSS, Chicago, IL, USA).
RESULTS

Hypoxia induced apoptosis of T lymphocytes
To investigate whether hypoxia affects T-cell apoptosis, we cultured freshly isolated blood T cells under normoxic or hypoxic conditions for 24 h. Next, apoptosis of T cells was assayed. The results demonstrated that hypoxia significantly induced the apoptosis of T cells ( Figure 1 ). As shown in Figure 1b , the percentage of apoptosis in normoxia is 7.7262.35%, and hypoxia increased the percentage of apoptosis to 16.3062.60% (P,0.05). The response of T cells to an inflammatory stimulus, LPS, was also evaluated in parallel experiments as a control. The results indicated that LPS did not affect apoptosis of T cells regardless if stimulated under normoxia or hypoxia conditions.
Effects of hypoxia on the expression of AR subtypes
Because hypoxia is a potent stimulus for the release of adenosine, we presume the adenosine-AR signaling pathway may play essential roles in hypoxia-induced apoptosis of T cells. Therefore, we assayed the expression pattern of genes encoding AR subtypes in T cells and the effect of hypoxia on the AR subtypes by using reverse transcription polymerase chain reaction. The experimental data demonstrated that all four AR subtypes were expressed in T cells during hypoxia. A 1 R was downregulated and A 2 R (including A 2a R and A 2b R) was upregulated 
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Hypoxia induced apoptosis of T cells via A 2 receptor
To confirm whether upregulation of A 2 R plays a role in the regulation of T-cell apoptosis, AR agonists and antagonists were used. Under normoxia, agonists specific for A 2a receptor (CGS21680) and nonspecific agonists for A 2b receptor (NECA) both increased T-cell apoptosis (P,0.05), whereas A 1 receptor-specific agonist (CPA) and A 3 receptor-specific agonist (IB-MECA) had no effect on T-cell survival (Figure 3a) . These results indicated that A 2a , and perhaps A 2b , are involved in the regulation of T-cell apoptosis. However, under hyp- These results suggest that the A 2 R signaling pathway is involved in the regulation of T-cell apoptosis.
CCR7 mediated the apoptosis of T cells and hypoxia inhibited the expression of CCR7 via A 2 R CCR7 expression is important for lymphocyte homing to tissues, and CCR7 also plays a role in CD8 1 T-cell protection from apoptosis. To determine whether CCR7 regulates hypoxia-induced apoptosis of T cells, we assayed the effects of hypoxia on the expression of CCR7. The results demonstrated that hypoxia significantly suppressed CCR7 expression in T cells (P,0.05) (Figure 4a) , and blocking the CCR7 signaling pathway with anti-CCR7 antibody was associated with a significant increase in the apoptosis of T cells (P,0.05) (Figure 4b ). These results indicate that CCR7 may play an essential role in hypoxia-induced T-cell apoptosis.
To evaluate whether A 2 R-regulated apoptosis of T cells under hypoxia is mediated by CCR7, a pharmacological approach using AR agonists and antagonists was chosen. T cells were treated with the AR agonist for 24 h under normoxic condition and the expression of CCR7 was assayed. As shown in Figure 5a and b, nonspecific agonist, NECA and A 2a receptor-specific agonist, CGS21680, can significantly inhibit CCR7 expression (P,0.05), whereas agonists for A 1 and A 3 receptors had no effects on the expression of CCR7. To further determine whether A 2b regulates CCR7 expression while accounting for the finding that hypoxia upregulated A 2 R, we cultured T cells under hypoxic conditions with A 2 R antagonists and assayed CCR7 expression. The results demonstrated that inactivation of both A 2a and A 2b by antagonists induced the upregulation of CCR7 (P,0.05) (Figure 5c and d) . Taken together, we confirmed that A 2 R-mediated induction of T-cell apoptosis under hypoxia partially acts via A 2 R suppression of CCR7. 
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DISCUSSION
Physiologic adaptation and pathophysiological response of immune cells to hypoxia is an area of intense investigation. The effect of hypoxia on the function of immune cells is considered to be essential mechanism for tumor immune escape. Many in vitro studies have shown that hypoxia regulates cytokines and the proliferation of lymphocytes. In this study, we found that hypoxia can induce the apoptosis of peripheral T cells. Apoptosis of T cells induced by hypoxia may represent a mechanism for tumor immunosuppression. However, it has been reported that hypoxia protected activated T cells from activation-induced cell death via the HIF-1-adrenomedullin cascade. 7 These contradictory conclusions indicate that the effects of hypoxia on T-cell survival are correlated with the activation status of T cells. Furthermore, our results showed that an inflammatory stimulus, LPS, had no effect on the apoptosis of T cells regardless if stimulated under normoxic or hypoxic conditions, suggesting that hypoxia, but not mediators such as LPS, is the potent stimulus inducing T-cell apoptosis.
Hypoxia can cause the marked accumulation of extracellular adenosine 29 and change the cellular function mediated by different ARs. The hypoxic microenvironment of solid tumors induces accumulation of adenosine. This accumulation of adenosine plays an essential role in cell-mediated antitumor immune responses. It has been reported that adenosine inhibited T-cell adhesion to tumor cells and cytotoxic activity via signaling primarily through A 2a and A 3 adenosine receptors. 1 Furthermore, it has been reported that the adenosine signaling pathway was associated with T-cell survival, 22, 23 but whether hypoxia-induced apoptosis of T cells is mediated by the adenosine signal, in addition to knowing which subtypes of AR are involved in this process, is unclear. To our knowledge, we are the first group to report that hypoxia differentially regulated AR subtype expression in T cells. Our results showed that hypoxia upregulated A 2a R and A 2b R, and the upregulation of A 2 R indicated that A 2 R may play an essential role in hypoxia-induced apoptosis of T cells. To test the A 2 R function on the induction of T-cell apoptosis, AR agonists and antagonists were used. Agonists for A 2a R (CGS21680) increased T-cell apoptosis under normoxic condition. Nonspecific agonists for A 2b R (NECA) also induced apoptosis of T cells. Under hypoxic conditions, specific antagonists for A 2a R and A 2b R reduced T-cell apoptosis, which further supported the role of A 2 R in the regulation of T-cell apoptosis. Furthermore, hypoxia downregulated A 1 R and did not change the expression of A 3 R, and as expected, agonist and antagonist experiments proved A 1 R and A 3 R indeed had no effect on T-cell survival. In conclusion, we have shown that hypoxia regulated the apoptosis of T cells mainly through the A 2 R signal pathway. This may represent a crucial mechanism by which the tumor microenvironment inhibits the antitumor activity of T lymphocytes.
For T cells, CCR7 not only exerts functions for lymphocyte homing but also plays an essential role in T-cell protection from apoptosis. 27 The CCR7
1 subset of circulating CD8 1 T cells is significantly less sensitive to apoptosis than CD8 1 T cells lacking CCR7. CCR7 expression correlated with higher Bcl-2 levels and signaling mechanism studies demonstrated that CCR7 protects effector T cells from apoptosis through the phosphatidylinositol 3-kinase/Akt pathway. 26 CCR7 also plays essential roles in regulating dendritic cell apoptosis via Aktmediated phosphorylation/inhibition of glycogen synthase kinase3beta. 30, 31 In this study, using an anti-CCR7 antibody, we further verified the anti-apoptosis effect of CCR7 (as shown in Figure 4b ). 
Hypoxia induces apoptosis of T cells JT Sun et al 81
We found hypoxia significantly inhibited CCR7 expression on T cells which implied that CCR7 may play important roles in hypoxiainduced T-cell apoptosis. Interestingly, our results demonstrated that hypoxia-induced downregulation of CCR7 in T cells was regulated by the A 2 R signaling pathway. These results suggest that hypoxia-induced inhibition of CCR7 regulated by the A 2 R signaling pathway may weaken the protective role of CCR7 in T-cell apoptosis and supports essential roles of CCR7 in hypoxia-induced apoptosis of T cells. Taken together, our results indicate that hypoxia-induced apoptosis of T cells may be mediated by the A 2 R signaling pathway by partially suppressing CCR7 expression. Therefore, novel cancer immunotherapy protocols may include the application of antagonists of A 2 R and/or activation of CCR7 to prevent the apoptosis of T cells and lead to more efficient elimination of tumors by T lymphocytes.
